Xynomic pharmaceuticals holdings, inc. (BCAC)
Income statement / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16
Operating expenses:
Research and development

0

0

-

-

0

0

-

-

-

-

-

-

General and administrative

0

0

-

-

0

0

-

-

-

-

-

-

General and administrative to related parties

-

0

-

-

0

0

-

-

-

-

-

-

Total operating expenses

1,780

-768

914

835

7,334

5,186

491

365

285

0

0

0

Loss from operations

-1,780

768

-914

-835

-7,334

-5,186

-491

-365

-285

0

0

0

Investment income

-

-

-

-

0

0

-

-

-

-

-

-

Interest income

0

-

-

-

0

0

-

-

-

-

-

-

Interest expenses to a related party

0

0

-

-

0

-

-

-

-

-

-

-

Loss from operations before income tax benefit

-

0

-

-

-

0

-

-

-

-

-

-

Interest income

-

-

1,248

-

-

-

562

341

172

0

0

0

Unrealized loss on marketable securities held in Trust Account

-

-

-2

-

-

-

-36

-17

3

0

0

0

Net loss

-577

1,988

331

266

-6,978

-4,642

34

-41

-109

0

0

0

Accretion to preferred share redemption value

-

-

-

-

0

0

-

-

-

-

-

-

Net loss attributable to ordinary shareholders

0

0

-

-

0

0

-

-

-

-

-

-

Other comprehensive income/(loss):
Foreign currency translation adjustment, net of nil income taxes

0

0

-

-

0

-

-

-

-

-

-

-

Unrealized gain on available for sale securities, net of nil income taxes

-

-

-

-

0

-

-

-

-

-

-

-

Less: reclassification adjustment for gain on available for sale securities realized in net income, net of nil income taxes

-

-

-

-

0

-

-

-

-

-

-

-

Total other comprehensive loss/(income)

0

0

-

-

0

-

-

-

-

-

-

-

Comprehensive loss attributable to ordinary shareholders

0

0

-

-

0

0

-

-

-

-

-

-

Weighted average ordinary shares outstanding - basic and diluted

46,273

44,623

2,477

-78,422

42,860

42,860

2,405

2,416

2,374

1,380

1,312

1,312

Loss per share - basic and diluted

-0.11

-0.07

-

-

-0.08

-0.11

-

-

-

-

-

-

Basic and diluted net income (loss) per ordinary share

-

-

0.01

-

-

-

-0.05

-0.06

-0.10

-0.02

0.00

0.00